Total Payments
$2,494
2023 Payments
$262.90
Companies
35
Transactions
169
Medicare Patients
212
Medicare Billing
$39,764
Payment Breakdown by Category
Food & Beverage$2,458 (98.6%)
Education$36.07 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,458 | 167 | 98.6% |
| Education | $36.07 | 2 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $409.91 | 32 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $322.70 | 13 | $0 (2023) |
| Allergan, Inc. | $206.27 | 13 | $0 (2020) |
| Lilly USA, LLC | $198.71 | 19 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $183.55 | 11 | $0 (2023) |
| Lundbeck LLC | $149.58 | 9 | $0 (2022) |
| Novo Nordisk Inc | $130.17 | 9 | $0 (2021) |
| Amgen Inc. | $101.50 | 8 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $92.21 | 7 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $64.71 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $262.90 | 14 | Otsuka America Pharmaceutical, Inc. ($86.79) |
| 2022 | $706.37 | 48 | ABBVIE INC. ($217.42) |
| 2021 | $462.71 | 32 | AbbVie Inc. ($133.90) |
| 2020 | $367.21 | 25 | Allergan, Inc. ($116.00) |
| 2019 | $363.42 | 19 | Otsuka America Pharmaceutical, Inc. ($90.80) |
| 2018 | $120.20 | 9 | Takeda Pharmaceuticals U.S.A., Inc. ($17.64) |
| 2017 | $211.23 | 22 | Lilly USA, LLC ($111.22) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: PSYCHIATRY | ||||||
| 04/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: PSYCHIATRY | ||||||
| 04/11/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: CNS | ||||||
| 04/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: CNS | ||||||
| 03/15/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: PSYCHIATRY | ||||||
| 03/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: INSOMNIA | ||||||
| 02/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 02/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: PSYCHIATRY | ||||||
| 01/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Diabetes | ||||||
| 01/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: NEUROSCIENCE | ||||||
| 12/30/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: PSYCHIATRY | ||||||
| 12/20/2022 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/14/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: PSYCHIATRY | ||||||
| 11/10/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Diabetes | ||||||
| 10/28/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: PSYCHIATRY | ||||||
| 10/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 36 | 57 | $17,385 | $2,771 |
| 2022 | 1 | 47 | 153 | $46,665 | $10,498 |
| 2021 | 1 | 54 | 191 | $52,975 | $14,024 |
| 2020 | 2 | 75 | 200 | $45,485 | $12,472 |
Total Patients
212
Total Services
601
Medicare Billing
$39,764
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 57 | $17,385 | $2,771 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 153 | $46,665 | $10,498 | 22.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 191 | $52,975 | $14,024 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 64 | 182 | $42,875 | $11,718 | 27.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 18 | $2,610 | $753.80 | 28.9% |
About Dr. Eugene Oliveto, MD
Dr. Eugene Oliveto, MD is a Psychiatry healthcare provider based in Bellevue, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811061203.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Oliveto, MD has received a total of $2,494 in payments from pharmaceutical and medical device companies, with $262.90 received in 2023. These payments were reported across 169 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,458).
As a Medicare-enrolled provider, Oliveto has provided services to 212 Medicare beneficiaries, totaling 601 services with total Medicare billing of $39,764. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Bellevue, NE
- Active Since 11/20/2006
- Last Updated 10/09/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1811061203
Products in Payments
- VRAYLAR (Drug) $603.80
- REXULTI (Drug) $368.85
- TRINTELLIX (Drug) $149.50
- TRULICITY (Drug) $116.92
- Ozempic (Drug) $98.12
- Aimovig (Biological) $72.82
- BRINTELLIX (Drug) $69.63
- Nuedexta (Drug) $67.19
- Trintellix (Drug) $65.47
- XIFAXAN (Drug) $64.71
- XARELTO (Drug) $52.17
- MOUNJARO (Drug) $50.55
- ELIQUIS (Drug) $49.35
- CAPLYTA (Drug) $43.25
- SUNOSI (Drug) $42.48
- ARISTADA (Drug) $41.06
- AIMOVIG (Biological) $38.30
- NUPLAZID (Drug) $34.69
- NURTEC ODT (Drug) $33.56
- Dayvigo (Drug) $32.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Bellevue
Dr. Arifulla Khan, Md, MD
Psychiatry — Payments: $457,425
Psychiatry $457,425
Dr. Patricia Paddison, M.d, M.D
Psychiatry — Payments: $102,774
Psychiatry $102,774
Dr. Mary-Ann Bolte, M.d, M.D
Psychiatry — Payments: $5,055
Psychiatry $5,055
Deborah Haynes, Md, MD
Psychiatry — Payments: $2,575
Psychiatry $2,575
Tatjana Deretic, M.d, M.D
Psychiatry — Payments: $1,806
Psychiatry $1,806
Russell Vandenbelt, M.d, M.D
Psychiatry — Payments: $1,310
Psychiatry $1,310